The Gladstone-UCSF Institute of Genomic Immunology is creating an ecosystem that brings together experts to develop transformative opportunities to harness the immune system to treat patients across a broad range of diseases.
In this inaugural symposium, scientists from around the world shared how they are using innovative technologies at the intersection of human immunology, genomics, CRISPR genome engineering, computational biology, and synthetic biology to answer key questions in human immunology and to repurpose the immune system for therapeutic benefit.
Alex Marson, Director, Gladstone-UCSF Institute of Genomic Immunology
Ananda Goldrath, UC San Diego
Camila Rosat Consiglio, Karolinska Institutet
Yapeng Su, Institute for Systems Biology
Aleksandra Deczkowska,Weizmann Institute of Science
María Casanova-Acebes, Centro Nacional de Investigaciones Oncológicas
Pratiksha Thakore, Broad Institute
Avery Posey, Jr., Perelman School of Medicine, University of Pennsylvania
Gladstone researchers fine-tuned CRISPR-Cas9 genome editing to work on human immune cells called monocytesNews Release Research (Publication) Data Science and Biotechnology Genomic Immunology Krogan Lab Marson Lab CRISPR/Gene Editing
The findings help point toward drug targets for new immune therapies to treat cancer and autoimmune diseaseGenomic Immunology Marson Lab